暂无分享,去创建一个
Subhashini Venugopalan | Boris Babenko | Gregory S. Corrado | Jorge Cuadros | Lily Peng | Paisan Ruamviboonsuk | Pinal Bavishi | Avinash V. Varadarajan | Yun Liu | Naama Hammel | Ashish Bora | Dale R. Webster | Akinori Mitani | Siva Balasubramanian | Sunny Virmani | Guilherme de Oliveira Marinho | Guilherme de Oliveira Marinho | Subhashini Venugopalan | G. Corrado | L. Peng | D. Webster | Yun Liu | Boris Babenko | Jorge A Cuadros | Ashish Bora | P. Ruamviboonsuk | S. Balasubramanian | S. Virmani | A. Mitani | A. Varadarajan | N. Hammel | Pinal Bavishi
[1] Thomas Brox,et al. Striving for Simplicity: The All Convolutional Net , 2014, ICLR.
[2] M. Schneck,et al. A multifocal electroretinogram model predicting the development of diabetic retinopathy , 2006, Progress in Retinal and Eye Research.
[3] Michael V. McConnell,et al. Prediction of cardiovascular risk factors from retinal fundus photographs via deep learning , 2017, Nature Biomedical Engineering.
[4] P. Scanlon. MICROVASCULAR COMPLICATIONS — RETINOPATHY ( JK SUN AND PS SILVA , 2017 .
[5] N. Wald,et al. Prevention of blindness by screening for diabetic retinopathy: a quantitative assessment. , 1989, BMJ.
[6] M. Abràmoff,et al. Improved Automated Detection of Diabetic Retinopathy on a Publicly Available Dataset Through Integration of Deep Learning. , 2016, Investigative ophthalmology & visual science.
[7] Jennifer I. Lim,et al. Diabetic Retinopathy Preferred Practice Pattern®. , 2019, Ophthalmology.
[8] Sergey Ioffe,et al. Rethinking the Inception Architecture for Computer Vision , 2015, 2016 IEEE Conference on Computer Vision and Pattern Recognition (CVPR).
[9] E. Stefánsson,et al. Diabetic eye screening with variable screening intervals based on individual risk factors is safe and effective in ophthalmic practice , 2020, Acta ophthalmologica.
[10] S. Sivaprasad,et al. Diagnostic Accuracy of Community-Based Diabetic Retinopathy Screening With an Offline Artificial Intelligence System on a Smartphone. , 2019, JAMA ophthalmology.
[11] M. Blumenkranz,et al. The sensitivity and specificity of single-field nonmydriatic monochromatic digital fundus photography with remote image interpretation for diabetic retinopathy screening: a comparison with ophthalmoscopy and standardized mydriatic color photography. , 2002, American journal of ophthalmology.
[12] A. Keech,et al. Biomarkers in Diabetic Retinopathy. , 2015, The review of diabetic studies : RDS.
[13] Subhashini Venugopalan,et al. Detection of anaemia from retinal fundus images via deep learning , 2019, Nature Biomedical Engineering.
[14] April Y. Maa,et al. Deep Learning and Glaucoma Specialists: The Relative Importance of Optic Disc Features to Predict Glaucoma Referral in Fundus Photographs. , 2018, Ophthalmology.
[15] J. Cunha-Vaz,et al. Diabetic Retinopathy Phenotypes of Progression to Macular Edema: Pooled Analysis From Independent Longitudinal Studies of up to 2 Years' Duration. , 2017, Investigative ophthalmology & visual science.
[16] 11. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes−2020 , 2019, Diabetes Care.
[17] Felipe A. Medeiros,et al. From Machine to Machine: An OCT-trained Deep Learning Algorithm for Objective Quantification of Glaucomatous Damage in Fundus Photographs , 2018, Ophthalmology.
[18] J. Shaw,et al. IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. , 2011, Diabetes research and clinical practice.
[19] Subhashini Venugopalan,et al. Development and Validation of a Deep Learning Algorithm for Detection of Diabetic Retinopathy in Retinal Fundus Photographs. , 2016, JAMA.
[20] Tien Yin Wong,et al. Diabetic retinopathy , 2010, The Lancet.
[21] H. Zisser,et al. A Virtual Type 2 Diabetes Clinic Using Continuous Glucose Monitoring and Endocrinology Visits , 2019, Journal of diabetes science and technology.
[22] F. Arcadu,et al. Deep learning algorithm predicts diabetic retinopathy progression in individual patients. , 2019, NPJ digital medicine.
[23] Jennifer K. Sun,et al. Diabetic Retinopathy: A Position Statement by the American Diabetes Association , 2017, Diabetes Care.
[24] Rishi P. Singh,et al. The role of anti-vascular endothelial growth factor (anti-VEGF) in the management of proliferative diabetic retinopathy , 2018, Drugs in context.
[25] N. Razavian,et al. Classification and mutation prediction from non–small cell lung cancer histopathology images using deep learning , 2018, Nature Medicine.
[26] Grading Diabetic Retinopathy from Stereoscopic Color Fundus Photographs - An Extension of the Modified Airlie House Classification: ETDRS Report Number 10. , 2020, Ophthalmology.
[27] M. Abràmoff,et al. Pivotal trial of an autonomous AI-based diagnostic system for detection of diabetic retinopathy in primary care offices , 2018, npj Digital Medicine.
[28] J. Shaw,et al. Retinal Arteriolar Caliber Predicts Incident Retinopathy , 2008, Diabetes Care.
[29] Matthew D. Davis,et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. , 2003, Ophthalmology.
[30] Janelle Downing,et al. Use of a Connected Glucose Meter and Certified Diabetes Educator Coaching to Decrease the Likelihood of Abnormal Blood Glucose Excursions: The Livongo for Diabetes Program , 2017, Journal of medical Internet research.
[31] L. Aiello,et al. Retinopathy in diabetes. , 2004, Diabetes care.
[32] B. Modjtahedi,et al. Two-Year Incidence of Retinal Intervention in Patients With Minimal or No Diabetic Retinopathy on Telemedicine Screening , 2019, JAMA ophthalmology.
[33] Grading diabetic retinopathy from stereoscopic color fundus photographs--an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group. , 1991, Ophthalmology.
[34] Jonathan Krause,et al. Grader variability and the importance of reference standards for evaluating machine learning models for diabetic retinopathy , 2017, Ophthalmology.
[35] M. Goldbaum,et al. Predicting glaucoma prior to its onset using deep learning , 2019 .
[36] R. T. Smith,et al. Artificial Intelligence to Stratify Severity of Age-Related Macular Degeneration (AMD) and Predict Risk of Progression to Late AMD , 2020, Translational vision science & technology.
[37] David S. Melnick,et al. International evaluation of an AI system for breast cancer screening , 2020, Nature.
[38] E. Finkelstein,et al. Development and Validation of a Deep Learning System for Diabetic Retinopathy and Related Eye Diseases Using Retinal Images From Multiethnic Populations With Diabetes , 2017, JAMA.
[39] D. Ting,et al. Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a review , 2016, Clinical & experimental ophthalmology.
[40] Bilson J. L. Campana,et al. Deep learning versus human graders for classifying diabetic retinopathy severity in a nationwide screening program , 2019, npj Digital Medicine.
[41] Mukund Sundararajan,et al. Attribution in Scale and Space , 2020, 2020 IEEE/CVF Conference on Computer Vision and Pattern Recognition (CVPR).
[42] M. Bachmann,et al. Incidence and Progression of Diabetic Retinopathy During 17 Years of a Population-Based Screening Program in England , 2012, Diabetes Care.
[43] Subhashini Venugopalan,et al. Predicting optical coherence tomography-derived diabetic macular edema grades from fundus photographs using deep learning , 2018, Nature Communications.
[44] Stephen J. Aldington,et al. UKPDS 50: Risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis , 2001, Diabetologia.
[45] Sebastian Thrun,et al. Dermatologist-level classification of skin cancer with deep neural networks , 2017, Nature.
[46] D. Hassabis,et al. Predicting conversion to wet age-related macular degeneration using deep learning , 2020, Nature Medicine.
[47] F. Ferris,et al. How effective are treatments for diabetic retinopathy? , 1993, JAMA.
[48] Ankur Taly,et al. Axiomatic Attribution for Deep Networks , 2017, ICML.